LLYEli Lilly

Pharma & Healthcare · US · Eli Lilly and Company

4 of 6 ratios computed · receipts verified server-side

Idiot Index

out of 100 · 4/6 ratios · FY 2023

The full receipt

Latest published value for each ratio, with the sector median for context and year-over-year change where the prior year is available.

Markup →
How much revenue per dollar of cost.
3.8724× revenue / costverified
$1 of cost becomes $3.87 of revenue
Sector median: 3.1882Median range for extraction in sector
FY 2023v1.0.0
Operational Markup →
Revenue per dollar of cost + operating expenses. The multiplier after legitimate operations.
1.3697× revenue / (cost + opex)verified
$1 of cost+opex becomes $1.37 of revenue
Sector median: 1.2871Median range for extraction in sector
FY 2023v1.0.0
Labor Share →
How much of every revenue dollar reaches workers.
Not yet computed for this company.
Executive Extraction →
How many times a CEO out-earns the median employee.
Not yet computed for this company.
Shareholder Extraction →
Dollars sent to shareholders for every dollar invested in R&D.
0.6257× buybacks+dividends / R&Dverified
$0.63 to shareholders per $1 in R&D — net reinvesting
Sector median: 0.7492Median range for extraction in sector
FY 2023v1.0.0
Capital Extraction →
How much of net profit goes to shareholders rather than back into the business.
0.7770× buybacks+dividends / net incomeverified
78% of net profit returned to shareholders, 22% reinvested
Sector median: 0.5294Median range for extraction in sector
FY 2023v1.0.0